Study identification

PURI

https://redirect.ema.europa.eu/resource/40850

EU PAS number

EUPAS21359

Study ID

40850

Official title and acronym

Anti-microbial resistance: choice of therapeutic interventions and outcomes for the treatment of infections caused by MDR Gram-negative pathogens

DARWIN EU® study

No

Study countries

Denmark
France
Greece
Netherlands
Romania

Study description

A systematic literature review of all available treatment guidelines and recommendations and the evidence behind them, and a European cross-sectional six-country survey of antibiotic prescribing patterns and algorithms used in clinical practice. As added values, we will include an MDR treatment outcome analysis using existing Danish data and, if accessible, other European individual-level hospital data.

Study status

Finalised
Research institution and networks

Institutions

Networks

Aarhus University Consortium (ad hoc)

Contact details

Henrik Toft Sørensen

Primary lead investigator
Study timelines

Date when funding contract was signed

Planned:
Actual:

Data collection

Planned:
Actual:

Date of final study report

Planned:
Actual:
Sources of funding
EMA
Study protocol
Initial protocol

Animicrobal resistance

English (428.5 KB - PDF)View document
Regulatory

Was the study required by a regulatory body?

Yes

Is the study required by a Risk Management Plan (RMP)?

Not applicable